📰 Master File News
Page 8 - Master File News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Master File. Real-time updates on events, politics, business and more.
January 26, 2022
/PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech start-up, announced that its cell manufacturing facility is now listed on the FDA...
January 16, 2022
Author: Christopher Musselwhite
December 6, 2021
On 26 November 2021, the Italian Revenue Agency issued the final version of the circular letter ("Circular") providing clarifications on the transfer…
December 3, 2021
Leading Producer of Controlled Substance APIs Now Supplying Lisdex API to Generic Drug Manufacturers Preparing for the 2023 Patent Expiry of Top-Selling Branded ADHD Therapy.
November 26, 2021
Transfer pricing is an international tax planning method which is becoming increasingly important for multinationals operating in Vietnam to consider.
October 19, 2021
We introduce the transfer pricing regulations in India, including the master file and CbCR requirements. This article is part one of a four-part series.
August 15, 2021
BILLA Gatesa i Jeffreyja Epsteina povezali su američka neuroznanstvenica i hrvatski imunolog, piše Rolling Stone.
June 11, 2021
Pennsylvania [US], June 11 (ANI): Bharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA) for COVAXIN and the US Food and Drug Administration (FDA) has recommended that the company go for the Biologics Licence Application (BLA) route, which is for full approval, with additional data.
June 11, 2021
Bharat Biotech's US partner Ocugen said it would no longer seek emergency approval for Covaxin, and would rather file for full approval of the anti-COVID shot
June 11, 2021
The FDA's verdict is the second roadblock Bharat Biotech has faced with respect to rolling Covaxin out in other parts of the world.